Effect of Repeated Administration of KT3-671, a Nonpeptide AT1 Receptor Antagonist, on Diurnal Variation in Blood Pressure, Heart Rate, and Locomotor Activity in Stroke-Prone Spontaneously Hypertensive Rats as Determined by Radiotelemetry

Koichiro Kawashima, Hideto Amano, Kazuko Fujimoto, Takeshi Suzuki, Takeshi Fujii, Seiichiro Mochizuki, Akira Tomiyama

Research output: Contribution to journalArticle

11 Citations (Scopus)

Abstract

KT3-671, a nonpeptide AT1 receptor antagonist, was administered to 20-week-old stroke-prone spontaneously hypertensive rats (SHRSP) daily for 3 weeks. Its effects on systolic, mean, and diastolic arterial blood pressure (SAP, MAP, DAP), heart rate and locomotor activity were investigated with radiotelemetry. A clear diurnal variation in blood pressure, heart rate, and loco-motor activity was observed in synchrony with the light cycle. KT3-671 at a daily dose of 10 mg/kg orally (p.o), produced a significant and consistent reduction in blood pressure, preventing the development of hypertension. KT3-671 reduced SAP more than DAP, suggesting that it may affect both vascular tone and cardiac output. Al-though KT3-671 did not affect diurnal rhythms in heart rate and locomotor activity, it did cause a slight but significant reduction in heart rate. The MAP determined 23 h after the administration of KT3-671 showed a significant reduction from the day 2 of therapy to the day 3 after discontinuation of therapy, suggesting a long duration of antihypertensive action. There was no rebound increase in blood pressure after discontinuation of KT3-671 therapy. These results suggest that KT3-671 may be potentially useful in the therapy of hypertension.

Original languageEnglish
Pages (from-to)411-416
Number of pages6
JournalJournal of Cardiovascular Pharmacology
Volume27
Issue number3
DOIs
Publication statusPublished - 1996 Jan 1

    Fingerprint

Keywords

  • At, receptor antagonist
  • Diurnal blood pressure rhythm
  • Heart rate
  • KT3-671
  • Radiotelemetry
  • Stroke-prone spontaneously hypertensive rats

ASJC Scopus subject areas

  • Pharmacology
  • Cardiology and Cardiovascular Medicine

Cite this